Literature DB >> 28191680

Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases.

François Niyonsaba1,2, Chanisa Kiatsurayanon1,3,4, Panjit Chieosilapatham1,3, Hideoki Ogawa1.   

Abstract

Host defense peptides/proteins (HDPs), also known as antimicrobial peptides/proteins (AMPs), are key molecules in the cutaneous innate immune system. AMPs/HDPs historically exhibit broad-spectrum killing activity against bacteria, enveloped viruses, fungi and several parasites. Recently, AMPs/HDPs were shown to have important biological functions, including inducing cell proliferation, migration and differentiation; regulating inflammatory responses; controlling the production of various cytokines/chemokines; promoting wound healing; and improving skin barrier function. Despite the fact that AMPs/HDPs protect our body, several studies have hypothesized that these molecules actively contribute to the pathogenesis of various skin diseases. For example, AMPs/HDPs play crucial roles in the pathological processes of psoriasis, atopic dermatitis, rosacea, acne vulgaris, systemic lupus erythematosus and systemic sclerosis. Thus, AMPs/HDPs may be a double-edged sword, promoting cutaneous immunity while simultaneously initiating the pathogenesis of some skin disorders. This review will describe the most common skin-derived AMPs/HDPs (defensins, cathelicidins, S100 proteins, ribonucleases and dermcidin) and discuss the biology and both the positive and negative aspects of these AMPs/HDPs in skin inflammatory/infectious diseases. Understanding the regulation, functions and mechanisms of AMPs/HDPs may offer new therapeutic opportunities in the treatment of various skin disorders.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  antimicrobial agent; infection; inflammation; skin immunity; therapeutic agent

Mesh:

Substances:

Year:  2017        PMID: 28191680     DOI: 10.1111/exd.13314

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  44 in total

1.  Phosphatidylglycerol Inhibits Toll-Like Receptor-Mediated Inflammation by Danger-Associated Molecular Patterns.

Authors:  Vivek Choudhary; Rawipan Uaratanawong; Ravi R Patel; Hirel Patel; Wendi Bao; Bernadette Hartney; Elyssa Cohen; Xunsheng Chen; Qing Zhong; Carlos M Isales; Wendy B Bollag
Journal:  J Invest Dermatol       Date:  2018-10-31       Impact factor: 8.551

Review 2.  Current insights into the role of human β-defensins in atopic dermatitis.

Authors:  P Chieosilapatham; H Ogawa; F Niyonsaba
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

Review 3.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

Review 4.  Skin microbiota-host interactions.

Authors:  Y Erin Chen; Michael A Fischbach; Yasmine Belkaid
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

5.  Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.

Authors:  F D'Amico; M Granata; E Skarmoutsou; C Trovato; G Lovero; P Gangemi; V Longo; M Pettinato; M C Mazzarino
Journal:  Inflamm Res       Date:  2018-03-31       Impact factor: 4.575

Review 6.  Immune responses and therapeutic options in psoriasis.

Authors:  Inna S Afonina; Elien Van Nuffel; Rudi Beyaert
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

7.  Candidalysin, a Virulence Factor of Candida albicans, Stimulates Mast Cells by Mediating Cross-Talk Between Signaling Pathways Activated by the Dectin-1 Receptor and MAPKs.

Authors:  Pu Song; Ge Peng; Hainan Yue; Takasuke Ogawa; Shigaku Ikeda; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  J Clin Immunol       Date:  2022-04-14       Impact factor: 8.542

8.  IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.

Authors:  Achilleas Floudas; Sean P Saunders; Tara Moran; Christian Schwartz; Emily Hams; Denise C Fitzgerald; James A Johnston; Graham S Ogg; Andrew N McKenzie; Patrick T Walsh; Padraic G Fallon
Journal:  J Immunol       Date:  2017-06-14       Impact factor: 5.422

Review 9.  Caveolin-1 as a possible target in the treatment for acne.

Authors:  Ilja L Kruglikov; Philipp E Scherer
Journal:  Exp Dermatol       Date:  2019-12-09       Impact factor: 4.511

Review 10.  Keratinocytes: innate immune cells in atopic dermatitis.

Authors:  P Chieosilapatham; C Kiatsurayanon; Y Umehara; J V Trujillo-Paez; G Peng; H Yue; L T H Nguyen; F Niyonsaba
Journal:  Clin Exp Immunol       Date:  2021-02-15       Impact factor: 5.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.